| 52-Week High | 6.95 |
|---|---|
| Last Price | 4.08 |
| Fibonacci 50% | 3.62 |
| Fibonacci 38.2% | 2.83 |
| 52-Week Low | 0.28 |
What happened to trxC stock?
Mar 30, 2022 · TransEnterix trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "TRXC." How do I buy shares of TransEnterix? Shares of TRXC can be purchased through any online brokerage account.
What does target price mean in stocks?
Mar 05, 2021 · View %COMPANY_NAME% TRXC investment & stock information. Get the latest %COMPANY_NAME% TRXC detailed stock quotes, stock data, …
What is the price of target stock?
About TRXC Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical ...
What is target stock price?
Get Asensus Surgical Inc (TRXC:undefined) real-time stock quotes, news, price and financial information from CNBC.
Is TRXC a good buy?
TransEnterix (TRXC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.Mar 5, 2021
What happens to TRXC stock?
TRXC stock will begin trading under the new name and ticker ASXC on March 5, 2021. The company said, “the name change [to Asensus Surgical] reflects the company's broader vision of shaping the future of surgery by integrating computer vision and machine learning with surgical robotics.”Feb 23, 2021
Is TRXC a penny stock?
TRXC Stock Is a Penny Stock And the reality is that many penny stocks carry a low price for a reason. In the case of TransEnterix, the company operates in the field of robotic surgery.Mar 2, 2021
What is the value of TRXC stock?
TRXC Price/Volume StatsCurrent price$4.0852-week highPrev. close$4.5452-week lowDay low$3.62VolumeDay high$4.77Avg. volume50-day MA$3.04Dividend yield1 more row
Will TRXC stock go up?
Ladenburg Thalmann does not see either upside or downside right now giving TRXC "" on their last update on Jan 20, 2021. The price target was changed from 3.47 to 0.57....Predicted Opening Price for TransEnterix, Inc of Wednesday, April 6, 2022.Fair opening price April 6, 2022Current price$0.70$0.70 (Undervalued)
What is the new ticker for TRXC?
Asensus Surgical (NYSE:ASXC) announced today that it formally completed its name and stock ticker change from TransEnterix (NYSE:TRXC). Research Park Triangle, N.C.-based Asensus announced last month that the company would change its name from TransEnterix to Asensus Surgical and introduce a new surgery category.Mar 5, 2021
Where can I buy TRXC stock?
Shares of TRXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
What is Tronclassic?
TRONCLASSIC (TRXC) is a cryptocurrency and operates on the Ethereum platform. TRONCLASSIC has a current supply of 1,000,000,000,000 with 0 in circulation.
TransEnterix
About TRXC
Some stock charts might currently not be supported. To try again, please refresh this page.
Signals & Forecast
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy.
Support, Risk & Stop-loss
There are mixed signals in the stock today. The TransEnterix, Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Is TransEnterix, Inc stock A Buy?
TransEnterix, Inc finds support from accumulated volume at $0.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Insiders are positive buying more shares than they are selling in TransEnterix, Inc
TransEnterix, Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Golden Star Signal
In the last 100 trades there were 5.45 million shares bought and 1.19 million shares sold. The last trade was done 381 days ago by Shameze Rampertab who bough 73.08 thousand shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
What the Market Says
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
The Bottom Line
There are several dynamics involved in a hospital’s decision to buy Senhance. Patient safety and surgical cost must be measured against both the upfront cost and training costs. The last is more important.
Cash, Cash Flow, and Market Cap
Asensus’ market entry has brought intense speculation and huge profits to traders who got in early.
What To Do With TRXC Stock
I estimate, after reviewing the company’s latest prospectus supplement as of Jan. 28 that TransEnterix has raised approximately $90 million ($89.66 million) after expenses. That means that its cash at that point was about 10.1% of its previously mentioned $885 million market capitalization.